| Product Code: ETC11530795 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Companion Diagnostic Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Companion Diagnostic Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Companion Diagnostic Market - Industry Life Cycle |
3.4 Sweden Companion Diagnostic Market - Porter's Five Forces |
3.5 Sweden Companion Diagnostic Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.6 Sweden Companion Diagnostic Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Sweden Companion Diagnostic Market Revenues & Volume Share, By Disease Area, 2021 & 2031F |
3.8 Sweden Companion Diagnostic Market Revenues & Volume Share, By Sample Type, 2021 & 2031F |
3.9 Sweden Companion Diagnostic Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Sweden Companion Diagnostic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Sweden leading to higher demand for companion diagnostics |
4.2.2 Rising adoption of personalized medicine in the healthcare sector |
4.2.3 Government initiatives to promote precision medicine and companion diagnostics |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval and commercialization of companion diagnostics |
4.3.2 High cost associated with development and implementation of companion diagnostics |
4.3.3 Limited awareness and understanding of companion diagnostics among patients and healthcare providers |
5 Sweden Companion Diagnostic Market Trends |
6 Sweden Companion Diagnostic Market, By Types |
6.1 Sweden Companion Diagnostic Market, By Technology Type |
6.1.1 Overview and Analysis |
6.1.2 Sweden Companion Diagnostic Market Revenues & Volume, By Technology Type, 2021 - 2031F |
6.1.3 Sweden Companion Diagnostic Market Revenues & Volume, By PCR-Based, 2021 - 2031F |
6.1.4 Sweden Companion Diagnostic Market Revenues & Volume, By Immunohistochemistry, 2021 - 2031F |
6.1.5 Sweden Companion Diagnostic Market Revenues & Volume, By Next-Gen Sequencing, 2021 - 2031F |
6.1.6 Sweden Companion Diagnostic Market Revenues & Volume, By Mass Spectrometry, 2021 - 2031F |
6.2 Sweden Companion Diagnostic Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Sweden Companion Diagnostic Market Revenues & Volume, By Drug Response Testing, 2021 - 2031F |
6.2.3 Sweden Companion Diagnostic Market Revenues & Volume, By Biomarker Testing, 2021 - 2031F |
6.2.4 Sweden Companion Diagnostic Market Revenues & Volume, By Genetic Testing, 2021 - 2031F |
6.2.5 Sweden Companion Diagnostic Market Revenues & Volume, By Disease Identification, 2021 - 2031F |
6.3 Sweden Companion Diagnostic Market, By Disease Area |
6.3.1 Overview and Analysis |
6.3.2 Sweden Companion Diagnostic Market Revenues & Volume, By Oncology, 2021 - 2031F |
6.3.3 Sweden Companion Diagnostic Market Revenues & Volume, By Cardiology, 2021 - 2031F |
6.3.4 Sweden Companion Diagnostic Market Revenues & Volume, By Neurology, 2021 - 2031F |
6.3.5 Sweden Companion Diagnostic Market Revenues & Volume, By Rare Diseases, 2021 - 2031F |
6.4 Sweden Companion Diagnostic Market, By Sample Type |
6.4.1 Overview and Analysis |
6.4.2 Sweden Companion Diagnostic Market Revenues & Volume, By Blood, 2021 - 2031F |
6.4.3 Sweden Companion Diagnostic Market Revenues & Volume, By Tissue, 2021 - 2031F |
6.4.4 Sweden Companion Diagnostic Market Revenues & Volume, By Saliva, 2021 - 2031F |
6.4.5 Sweden Companion Diagnostic Market Revenues & Volume, By Urine, 2021 - 2031F |
6.5 Sweden Companion Diagnostic Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Sweden Companion Diagnostic Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.5.3 Sweden Companion Diagnostic Market Revenues & Volume, By Diagnostic Centers, 2021 - 2031F |
6.5.4 Sweden Companion Diagnostic Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.5.5 Sweden Companion Diagnostic Market Revenues & Volume, By Pharmaceuticals, 2021 - 2031F |
7 Sweden Companion Diagnostic Market Import-Export Trade Statistics |
7.1 Sweden Companion Diagnostic Market Export to Major Countries |
7.2 Sweden Companion Diagnostic Market Imports from Major Countries |
8 Sweden Companion Diagnostic Market Key Performance Indicators |
8.1 Adoption rate of companion diagnostics by healthcare facilities in Sweden |
8.2 Number of partnerships and collaborations between diagnostic companies and pharmaceutical firms for companion diagnostics development |
8.3 Rate of reimbursement for companion diagnostics by public and private healthcare payers in Sweden |
9 Sweden Companion Diagnostic Market - Opportunity Assessment |
9.1 Sweden Companion Diagnostic Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
9.2 Sweden Companion Diagnostic Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Sweden Companion Diagnostic Market Opportunity Assessment, By Disease Area, 2021 & 2031F |
9.4 Sweden Companion Diagnostic Market Opportunity Assessment, By Sample Type, 2021 & 2031F |
9.5 Sweden Companion Diagnostic Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Sweden Companion Diagnostic Market - Competitive Landscape |
10.1 Sweden Companion Diagnostic Market Revenue Share, By Companies, 2024 |
10.2 Sweden Companion Diagnostic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here